MITHRIDATE

Trial MITHRIDATE
Cancer Type Haematological Cancers
Hospital(s) Belfast City Hospital
Information

A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

Click Here to view CancerHelpUK trial summary
Posted in .